Measles outbreak in a vaccinated school population: epidemiology, chains of transmission and the role of vaccine failures.

Journal ListAm J Public Healthv.77(4); Apr 1987PMC1646939
Am J Public Health. 1987 April; 77(4): 434–438.
PMCID: PMC1646939
B M Nkowane, S W Bart, W A Orenstein, and M Baltier
Copyright and License information ▼
Copyright notice


An outbreak of measles occurred in a high school with a documented vaccination level of 98 per cent. Nineteen (70 per cent) of the cases were students who had histories of measles vaccination at 12 months of age or older and are therefore considered vaccine failures. Persons who were unimmunized or immunized at less than 12 months of age had substantially higher attack rates compared to those immunized on or after 12 months of age. Vaccine failures among apparently adequately vaccinated individuals were sources of infection for at least 48 per cent of the cases in the outbreak. There was no evidence to suggest that waning immunity was a contributing factor among the vaccine failures. Close contact with cases of measles in the high school, source or provider of vaccine, sharing common activities or classes with cases, and verification of the vaccination history were not significant risk factors in the outbreak. The outbreak subsided spontaneously after four generations of illness in the school and demonstrates that when measles is introduced in a highly vaccinated population, vaccine failures may play some role in transmission but that such transmission is not usually sustained.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Hilleman MR, Buynak EB, Weibel RE, Stokes J, Jr, Whitman JE, Jr, Leagus MB. Development and evaluation of the Moraten measles virus vaccine. JAMA. 1968 Oct 14;206(3):587–590. [PubMed]
Brunell PA, Weigle K, Murphy MD, Shehab Z, Cobb E. Antibody response following measles-mumps-rubella vaccine under conditions of customary use. JAMA. 1983 Sep 16;250(11):1409–1412. [PubMed]
Orenstein WA, Bernier RH, Dondero TJ, Hinman AR, Marks JS, Bart KJ, Sirotkin B. Field evaluation of vaccine efficacy. Bull World Health Organ. 1985;63(6):1055–1068. [PMC free article] [PubMed]
Hayden GF. Measles vaccine failure. A survey of causes and means of prevention. Clin Pediatr (Phila) 1979 Mar;18(3):155–167. [PubMed]
Weibel RE, Buynak EB, McLean AA, Hilleman MR. Follow-up surveillance for antibody in human subjects following live attenuated measles, mumps, and rubella virus vaccines. Proc Soc Exp Biol Med. 1979 Nov;162(2):328–332. [PubMed]
Marks JS, Halpin TJ, Orenstein WA. Measles vaccine efficacy in children previously vaccinated at 12 months of age. Pediatrics. 1978 Dec;62(6):955–960. [PubMed]
Lerman SJ, Gold E. Measles in children previously vaccinated against measles. JAMA. 1971 May 24;216(8):1311–1314. [PubMed]
Shasby DM, Shope TC, Downs H, Herrmann KL, Polkowski J. Epidemic measles in a highly vaccinated population. N Engl J Med. 1977 Mar 17;296(11):585–589. [PubMed]
Shelton JD, Jacobson JE, Orenstein WA, Schulz KF, Donnell HD., Jr Measles vaccine efficacy: influence of age at vaccination vs. duration of time since vaccination. Pediatrics. 1978 Dec;62(6):961–964. [PubMed]
Krugman S. Present status of measles and rubella immunization in the United States: a medical progress report. J Pediatr. 1977 Jan;90(1):1–12. [PubMed]
Krugman S. Further-attenuated measles vaccine: characteristics and use. Rev Infect Dis. 1983 May-Jun;5(3):477–481. [PubMed]
Articles from American Journal of Public Health are provided here courtesy of American Public Health Association